Precision Biosciences Inc (DTIL) — 10-Q Filings
All 10-Q filings from Precision Biosciences Inc. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Precision BioSciences' Revenue Plummets, Net Loss Widens Dramatically
— Nov 3, 2025 Risk: high
PRECISION BIOSCIENCES INC (DTIL) reported a significant decline in revenue and a widening net loss for the nine months ended September 30, 2025. Revenue plummet -
Precision BioSciences' Losses Widen Amidst R&D Push
— Aug 7, 2025 Risk: high
PRECISION BIOSCIENCES INC reported a net loss of $25.3 million for the three months ended June 30, 2025, a significant increase from the $18.7 million net loss -
Precision BioSciences Q3 2024 Update
— Nov 4, 2024 Risk: medium
Precision BioSciences Inc. reported its third-quarter financial results for the period ending September 30, 2024. The company's filing details its financial pos -
Precision BioSciences Q2 2024 Update
— Aug 1, 2024 Risk: medium
Precision BioSciences Inc. reported its financial results for the quarter ended June 30, 2024. The company's filing indicates ongoing research and development a -
Precision BioSciences Files 10-Q for Period Ending March 31, 2024
— May 13, 2024 Risk: medium
PRECISION BIOSCIENCES INC (DTIL) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Precision BioSciences Inc. filed a 10-Q report for the quarterly
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX